Moderna says vaccine will work against new Coronavirus variants
Moderna Inc said on Monday that it believes its COVID-19 vaccine protects against the new variants found in Britain and South Africa.
The company said in a news release it found no reduction in the antibody response against the variant found in Britain. Against the South African variant, it found a reduced response but still believed its two-dose regimen would provide protection.
Moderna expects its current vaccine will remain protective for at least a year after completing the two-dose course. It does not expect to test a third dose until at least six months after that course is finished.
Pfizer Inc and BioNTech SE have also said tests showed their vaccine is effective against the variant found in Britain, but have not yet disclosed results against the South African variant.